LNC
29
4
NEE
44
3
PFE
33
-2
GE
64
4
TSCO
48
5
EXPE
88
2
SLG
38
3
NWSA
75
8
FIS
48
5
URI
39
3
TGNA
50
2
ZBH
71
3
PCG
66
5
HES
53
4
PPG
60
3
AXP
67
4
D
35
2
HOG
29
2
CHRW
54
3
EMR
62
6
LNC
29
4
NEE
44
3
PFE
33
-2
GE
64
4
TSCO
48
5
EXPE
88
2
SLG
38
3
NWSA
75
8
FIS
48
5
URI
39
3
TGNA
50
2
ZBH
71
3
PCG
66
5
HES
53
4
PPG
60
3
AXP
67
4
D
35
2
HOG
29
2
CHRW
54
3
EMR
62
6
Financhill
Back

Checkpoint Therapeutics 10K Form

Sell
49

CKPT
Checkpoint Therapeutics

Last Price:
$3.63
Seasonality Move:
-0.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CKPT News And Ratings

See the #1 stock for the next 7 days that we like better than CKPT

CKPT Financial Statistics

Sales & Book Value

Annual Sales: $103K
Cash Flow: $-11.2M
Price / Cash Flow: 0
Annual Sales: $-0.27
Price / Book: 0

Profitability

EPS (TTM): -1.84000
Net Income (TTM): $-46.5M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -632.35%

Checkpoint Therapeutics Earnings Forecast

Key Checkpoint Therapeutics Financial Ratios

  • The Research & Development expenses have been 42,297.09% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CKPT is -50,336.89% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Checkpoint Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CKPT
CUSIP: 162828
Website: checkpointtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.26
Quick Ratio: 0.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CKPT Technical Analysis vs Fundamental Analysis

Sell
49
Checkpoint Therapeutics (CKPT) is a Sell

Is Checkpoint Therapeutics a Buy or a Sell?